Fresenius Net Income Surges By 24% In 2007 At Euro 11,358 Million

Fresenius Group, a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care, has reported net profit growth of 24.2 per cent during the year ended December 2007 to Euro 410 million as against Euro 330 million in the previous year. The Group's sales increased by 5.4 per cent to Euro 11,358 million from Euro 10,777 million. The earning per share worked out to Euro 2.64 as compared to Euro 2.15 after adjusting for share split.

Govt to issue new guidelines for medical device industry

The domestic medical equipment industry is estimated at 2.17 billion dollars and is growing at 15 per cent per annum. It is estimated to reach 4.97 billion dollars by 2012.

"The Government is in the process of creating a new and better regulatory structure for the medical devices industry

India No More Hot Offshore R&D Centre

Few companies will look at India as their destination for offshore R&D centres in the next 18 months. In fact, there is already a sort of slowdown in the number of such units being set up in the country. From 75 new offshore R&D centres in 2005, the number has dwindled to just 15 last year. There are about 600 MNC captives in India and R&D offshoring activity in the country is estimated $6 billion and is seen as growing at 23%. Software product development captures over 50% of R&D market, with the balance contributed by embedded systems space.

Bigtec Invests Rs. 10 Cr For Advanced Biotech Lab At IISc Campus

In a bid to advance its biomedical diagnostic research and development efforts, Bigtec Pri vate Limited has opened a state of the art laboratory at the Society for Innovation & Development (SID) Entrepreneurship Centre in the Indian Institute of Science (IISc) Campus, Bangalore at an investment of Rs. 10 crore.

Marck To Enter Malaysia, S’pore & Indonesia Markets

The Ahmedabad based Pharmaceutical company Marck Biosciences Ltd. is all set to foray into the Far East countries like Malaysia, Singapore and Indonesian markets by the end of June 2008. The company is planning to offer 12 new products in the existing therapeutic segment and these markets.

RG Stone Urology Plans Telemedicine, Satellite Centres In India

The RG Stone Urology & Laparoscopy Hospital, the pioneer super specialty urology institute in Delhi, is planning to set up telemedicine facilities and satellite centres across the country within the year 2009. The hospital is carrying out the expansion projects in India by setting up specialty centres in various cities with a total investment of around Rs 80 crore (USD 20 million).

Medical Equipment Cos Ask Govt To Bring Down Import Duty To 5% In Union Budget

Medical equipment manufacturers and providers have jointly sought a reduction in import duty on medical equipments in the Union Budget 2008-09 for the benefit of industry and patients.

Cardiac Completes Certification For HeartCentrix With NextGen

Cardiac Science Corporation, a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, said it completed certification for its HeartCentrix ECG informatics software with NextGen Healthcare Information Systems. NextGen is a leading developer and provider of computer based practice management and electronic medical record (EMR) systems for medical group practices and healthcare systems.

Dow Reveals Health and Hygiene Product Applications for INFUSE™ Olefin Block Copolymers at INDEX 08

This week Dow delivers a series of technical presentations at the INDEX 08 exhibition in Geneva detailing how its INFUSE™ Olefin Block Copolymers (OBCs) can create powerful new product application opportunities for brand owners and converters in the health and hygiene market segment. INFUSE OBCs, one of Dow’s latest resin product families, are an exciting development in olefin elastomers because of a distinct block architecture that delivers excellent new combinations of resin performance and processing properties.

J&J expands its presence in orthopaedics

US healthcare giant Johnson & Johnson has plans to roll out India-specific devices soon, in keeping with its plans to expand its presence in the Indian orthopaedic deices market. These new products will be designed to suit the Indian market and will be priced economically.

Transasia Bio-Medicals Ltd. gets ISO 13485

Transasia Bio-Medicals Ltd., a player in the clinical diagnostics segment in Indian healthcare sector, which aids in diagnosing life threatening diseases such as AIDS, tuberculosis, cancer, diabetes etc. has been awarded ISO 13485 ( Quality Management Systems for Medical Devices) by UL India, a certifying body to foster quality assurance and improvement.